Gut Dysbiosis and IL-21 Response in Patients with Severe COVID-19
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 1
Curated date: 2021/07/03
Curator: Claregrieve1
Revision editor(s): Claregrieve1, WikiWorks, Peace Sandy
Subjects
- Location of subjects
- India
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- COVID-19 2019 novel coronavirus,2019 novel coronavirus infection,2019-nCoV,2019-nCoV infection,beta-CoV,beta-CoVs,betacoronavirus,coronavirus disease 2019,SARS-coronavirus 2,SARS-CoV-2,severe acute respiratory syndrome coronavirus 2,severe acute respiratory syndrome coronavirus 2 infectious disease,β-coronavirus,β-CoV,β-CoVs,COVID-19,cOVID-19
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Healthy controls
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Asymptomatic COVID-19 patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Asymptomatic COVID-19 patients (positive for SARS-CoV-2 in an RT-PCR diagnostic assay) with no symptoms
- Group 0 sample size Number of subjects in the control (unexposed) group
- 10
- Group 1 sample size Number of subjects in the case (exposed) group
- 10
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V3-V4
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- relative abundances
- Statistical test
- LEfSe
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- No
- LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
- 2
Signature 1
Source: Figure 3a
Description: Differential microbial abundance between healthy volunteers and asymptomatic COVID-19 patients
Abundance in Group 1: increased abundance in Asymptomatic COVID-19 patients
Revision editor(s): Claregrieve1, Merit
Signature 2
Source: Figure 3a
Description: Differential microbial abundance between healthy volunteers and asymptomatic COVID-19 patients
Abundance in Group 1: decreased abundance in Asymptomatic COVID-19 patients
Revision editor(s): Fatima, Claregrieve1
Experiment 2
Curated date: 2021/07/03
Curator: Claregrieve1
Revision editor(s): Claregrieve1, WikiWorks, Victoria
Subjects
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- COVID-19 patients (positive for SARS-CoV-2 in an RT-PCR diagnostic assay) with mild symptoms and no requirement of oxygen support/ventilator
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 3b
Description: Differential microbial abundance between healthy volunteers and mild COVID-19 patients
Abundance in Group 1: increased abundance in Asymptomatic COVID-19 patients
Revision editor(s): Claregrieve1, Merit
Signature 2
Source: Figure 3b
Description: Differential microbial abundance between healthy volunteers and mild COVID-19 patients
Abundance in Group 1: decreased abundance in Asymptomatic COVID-19 patients
Revision editor(s): Fatima, Claregrieve1
Experiment 3
Curated date: 2021/07/04
Curator: Claregrieve1
Revision editor(s): Claregrieve1, WikiWorks, Victoria
Subjects
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Severe COVID-19 patients
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- COVID-19 patients (positive for SARS-CoV-2 in an RT-PCR diagnostic assay) with severe disease and requiring oxygen support/ventilator
Lab analysis
Statistical Analysis
Signature 1
Source: Figure 3c
Description: Differential microbial abundance between healthy volunteers and severe COVID-19 patients
Abundance in Group 1: increased abundance in Severe COVID-19 patients
Revision editor(s): Claregrieve1
Signature 2
Source: Figure 3c
Description: Differential microbial abundance between healthy volunteers and severe COVID-19 patients
Abundance in Group 1: decreased abundance in Severe COVID-19 patients
Revision editor(s): Claregrieve1